FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting beta-catenin through mRNA demethylation. Zhou, S. et al. (59). This evidence concerns the gene CTNNB1 and skin squamous cell carcinoma.